Itzstein, Mark von.
Mark von Itzstein
VIAF ID: 102981046 (Personal)
Permalink: http://viaf.org/viaf/102981046
Preferred Forms
-
- 100 1 _ ‡a Itzstein, Mark von
-
-
-
- 100 1 _ ‡a Itzstein, Mark von
- 100 1 _ ‡a Itzstein, Mark von
-
- 100 0 _ ‡a Mark von Itzstein
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
All major cholesterol-dependent cytolysins use glycans as cellular receptors | |
Approach for Profiling of Glycosphingolipid Glycosylation by Multiplexed Capillary Gel Electrophoresis Coupled to Laser-Induced Fluorescence Detection To Identify Cell-Surface Markers of Human Pluripotent Stem Cells and Derived Cardiomyocytes | |
Characterization of the Phase-Variable Autotransporter Lav Reveals a Role in Host Cell Adherence and Biofilm Formation in Nontypeable Haemophilus influenzae | |
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance | |
Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone | |
A dual drug regimen synergistically blocks human parainfluenza virus infection. | |
Efficient Blocking of Enterovirus 71 Infection by Heparan Sulfate Analogues Acting as Decoy Receptors | |
Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen | |
Functional and structural characterization of a heparanase | |
Glycans as Ligands in Bioinorganic Chemistry. Probing the Interaction of a Trinuclear Platinum Anticancer Complex with Defined Monosaccharide Fragments of Heparan Sulfate | |
Glycointeractions in bacterial pathogenesis. | |
How Size Matters: Diversity for Fragment Library Design | |
The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design | |
Influenza Virus Sialidase - A Drug Discovery Target | |
Microbial glycobiology : structures, relevance and applications | |
NAD+ cleavage activity by animal and plant TIR domains in cell death pathways | |
Neisseria gonorrhoeae Becomes Susceptible to Polymyxin B and Colistin in the Presence of PBT2 | |
Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression | |
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis | |
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection | |
SialoGlyco chemistry and biology I : biosynthesis, structural diversity and sialoglycopathologies | |
SialoGlyco Chemistry and Biology II : Tools and Techniques to Identify and Capture Sialoglycans | |
A sialosyl sulfonate as a potent inhibitor of influenza virus replication | |
Structural insights into human parainfluenza virus type-3 haemagglutinin-neuraminidase using unsaturated 3- N-substituted sialic acids as probes. | |
Substitution-Inert Polynuclear Platinum Complexes as Metalloshielding Agents for Heparan Sulfate. | |
A Sulfonozanamivir Analogue has Potent Anti-influenza Virus Activity. | |
Tetramerization is essential for the enzymatic function of the Pseudomonas aeruginosa virulence factor UDP-glucose pyrophosphorylase | |
Unravelling the Role of O-glycans in Influenza A Virus Infection |